» Articles » PMID: 33965839

Spectroscopic and Biochemical Characterization of Metallo-β-lactamase IMP-1 with Dicarboxylic, Sulfonyl, and Thiol Inhibitors

Abstract

In an effort to probe the biophysical mechanisms of inhibition for ten previously-reported inhibitors of metallo-β-lactamases (MBL) with MBL IMP-1, equilibrium dialysis, metal analyses coupled with atomic absorption spectroscopy (AAS), native state mass spectrometry (native MS), and ultraviolet-visible spectrophotometry (UV-VIS) were used. 6-(1H-tetrazol-5-yl) picolinic acid (1T5PA), ANT431, D/l-captopril, thiorphan, and tiopronin were shown to form IMP-1/Zn(II)/inhibitor ternary complexes, while dipicolinic acid (DPA) and 4-(3-aminophenyl)pyridine-2,6-dicarboxylic acid (3AP-DPA) stripped some metal from the active site of IMP but also formed ternary complexes. DPA and 3AP-DPA stripped less metal from IMP-1 than from VIM-2 but stripped more metal from IMP-1 than from NDM-1. In contrast to a previous report, pterostilbene does not appear to bind to IMP-1 under our conditions. These results, along with previous studies, demonstrate similar mechanisms of inhibition toward different MBLs for different MBL inhibitors.

Citing Articles

Machine Learning Models Identify Inhibitors of New Delhi Metallo-β-lactamase.

Cheng Z, Aitha M, Thomas C, Sturgill A, Fairweather M, Hu A J Chem Inf Model. 2024; 64(10):3977-3991.

PMID: 38727192 PMC: 11129921. DOI: 10.1021/acs.jcim.3c02015.


Small-molecule inhibitors of bacterial-producing metallo-β-lactamases: insights into their resistance mechanisms and biochemical analyses of their activities.

Ayipo Y, Chong C, Mordi M RSC Med Chem. 2023; 14(6):1012-1048.

PMID: 37360393 PMC: 10285742. DOI: 10.1039/d3md00036b.


Synthetic Studies with Bacitracin A and Preparation of Analogues Containing Alternative Zinc Binding Groups.

Buijs N, Vlaming H, van Haren M, Martin N Chembiochem. 2022; 23(24):e202200547.

PMID: 36287040 PMC: 10099996. DOI: 10.1002/cbic.202200547.

References
1.
Chu Y, Afzal-Shah M, Houang E, Palepou M, LYON D, Woodford N . IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother. 2001; 45(3):710-4. PMC: 90361. DOI: 10.1128/AAC.45.3.710-714.2001. View

2.
Ju L, Cheng Z, Fast W, Bonomo R, Crowder M . The Continuing Challenge of Metallo-β-Lactamase Inhibition: Mechanism Matters. Trends Pharmacol Sci. 2018; 39(7):635-647. PMC: 6005755. DOI: 10.1016/j.tips.2018.03.007. View

3.
Cornaglia G, Riccio M, Mazzariol A, Lauretti L, Fontana R, Rossolini G . Appearance of IMP-1 metallo-beta-lactamase in Europe. Lancet. 1999; 353(9156):899-900. DOI: 10.1016/s0140-6736(98)05954-6. View

4.
Thomas C, Cheng Z, Yang K, Hellwarth E, Yurkiewicz C, Baxter F . Probing the mechanisms of inhibition for various inhibitors of metallo-β-lactamases VIM-2 and NDM-1. J Inorg Biochem. 2020; 210:111123. DOI: 10.1016/j.jinorgbio.2020.111123. View

5.
Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H . Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother. 1994; 38(1):71-8. PMC: 284399. DOI: 10.1128/AAC.38.1.71. View